Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Cell Separation Technologies Market Size, Share, and Trends - Global Forecast 2026-2032 | Automation, AI, and Cell Therapy Demand Drive 8.66% CAGR Toward USD 19.90 Billion

globenewswire.com

Cell Separation Technologies Market Size, Share, and Trends - Global Forecast 2026-2032 | Automation, AI, and Cell Therapy Demand Drive 8.66% CAGR Toward USD 19.90 Billion Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Cell Separation Technologies Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

This market research report examines the global Cell Separation Technologies Market, projected to reach USD 12.05 billion in 2026 and expand at a CAGR of 8.66% to USD 19.90 billion by 2032. It analyzes the technologies, applications, regional dynamics, and competitive factors shaping demand across research, clinical, and biomanufacturing environments.

Market Overview and Growth Drivers

Cell separation technologies enable researchers, clinical laboratories, biomanufacturers, and cell therapy developers to isolate targeted cell populations from complex biological samples. Major technologies include:

Demand is rising with the expansion of cell and gene therapy pipelines, flow cytometry, and single-cell analysis. Applications span oncology, immunology, regenerative medicine, stem cell research, infectious disease research, and diagnostics. The market analysis supports strategic planning by clarifying where automation, clinical-grade processing, and advanced research workflows are creating commercial opportunities.

Transformative Shifts in Cell Separation

The market is moving from stand-alone instruments toward integrated sample-to-answer ecosystems. Users increasingly seek platforms that combine enrichment, washing, concentration, activation, and documentation while reducing contamination risks. In cell therapy manufacturing, closed and automated processing can minimize manual handling and improve batch consistency.

High-dimensional biology is also changing purchasing criteria. Single-cell RNA sequencing, mass cytometry, spatial biology, and multi-omics require reliable cell isolation and preparation. Buyers now evaluate cell viability, purity, throughput, downstream compatibility, cell stress, digital traceability, chain-of-identity controls, reproducibility, and regulatory readiness.

Artificial Intelligence and Automation

Artificial intelligence is influencing system design, operation, and validation. AI-enabled image analysis can support cell identification, while machine learning may improve gating strategies, rare-cell detection, viability prediction, and complex immunophenotyping.

In regulated settings, successful adoption depends on explainability, auditability, validated data governance, and human oversight. These insights allow decision-makers to assess automation investments against measurable gains in throughput, quality control, and compliance.

Regional and Economic Group Insights

ASEAN, the GCC, the European Union, BRICS, G7, and NATO-aligned markets are assessed in relation to research capacity, procurement conditions, regulation, healthcare investment, and biomedical preparedness. These comparisons can inform market-entry priorities and reduce risks associated with regional regulatory and supply-chain differences.

Strategic Priorities for Industry Leaders

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cell Separation Technologies Market, by Technology

7.1. Introduction

7.2. Acoustic Separation

7.3. Centrifugation

7.3.1. Batch

7.3.2. Continuous

7.4. Field Flow Fractionation

7.5. Filtration

7.5.1. Cross Flow

7.5.2. Dead End

7.6. Magnetic Activated Cell Sorting

7.6.1. Negative Selection

7.6.2. Positive Selection

7.7. Microfluidics

7.7.1. Deterministic Lateral Displacement

7.7.2. Hydrodynamic Separation

8. Cell Separation Technologies Market, by Product

8.1. Introduction

8.2. Consumables

8.2.1. Filters

8.2.2. Kits

8.2.3. Reagents

8.3. Instruments

8.3.1. Acoustic Separators

8.3.2. Centrifuges

8.3.3. Filtration Systems

8.3.4. Magnetic Separators

8.3.5. Microfluidic Devices

8.4. Software

8.4.1. Analysis Software

8.4.2. Automation Software

9. Cell Separation Technologies Market, by Cell Type

9.1. Introduction

9.2. Blood Cells

9.3. Cancer Cells

9.4. Microorganisms

9.5. Stem Cells

10. Cell Separation Technologies Market, by Separation Mode

10.1. Introduction

10.2. Batch

10.3. Continuous

11. Cell Separation Technologies Market, by Application

11.1. Introduction

11.2. Biopharmaceutical Processing

11.2.1. Downstream Processing

11.2.2. Upstream Processing

11.3. Clinical Diagnostics

11.3.1. Cancer Diagnosis

11.3.2. Infectious Disease Testing

11.4. Research

11.4.1. Cell Biology

11.4.2. Drug Discovery

11.4.3. Genomics

11.5. Therapeutics

11.5.1. Cell Therapy

11.5.2. Gene Therapy

12. Cell Separation Technologies Market, by End User

12.1. Introduction

12.2. Academic Institutes

12.3. Biotechnology Companies

12.4. Contract Research Organizations

12.5. Hospitals

12.6. Research Laboratories

13. Cell Separation Technologies Market, by Region

13.1. Introduction

13.2. Asia-Pacific

13.3. Europe

13.4. North America

13.5. Latin America

13.6. Africa

13.7. Middle East

14. Cell Separation Technologies Market, by Group

14.1. Introduction

14.2. NATO

14.3. G7

14.4. European Union

14.5. BRICS

14.6. ASEAN

14.7. GCC

15. Cell Separation Technologies Market, by Country

15.1. Introduction

15.2. United States

15.3. China

15.4. Germany

15.5. Japan

15.6. India

15.7. United Kingdom

15.8. France

15.9. Canada

15.10. Italy

15.11. Australia

15.12. South Korea

15.13. Brazil

15.14. Mexico

15.15. Russia

15.16. Spain

16. Competitive Landscape

16.1. Market Share Analysis, 2025

16.2. Market Concentration Analysis, 2025

16.2.1. Concentration Ratio (CR)

16.2.2. Herfindahl Hirschman Index (HHI)

16.3. Recent Developments & Impact Analysis, 2025

16.4. Product Portfolio Analysis, 2025

16.5. Benchmarking Analysis, 2025

17. Company Profiles

17.1. 10x Genomics, Inc.

17.2. Akadeum Life Sciences, Inc.

17.3. Becton, Dickinson and Company

17.4. Bio-Rad Laboratories, Inc.

17.5. Bio-Techne Corporation

17.6. Cellares Corporation

17.7. Corning Incorporated

17.8. Danaher Corporation

17.9. Eppendorf SE

17.10. Esco Micro Pte. Ltd.

17.11. GE HealthCare Technologies Inc.

17.12. GenScript Biotech Corporation

17.13. Invent Biotechnologies, Inc.

17.14. LevitasBio, Inc.

17.15. Lonza Group AG

17.16. Merck KGaA

17.17. Miltenyi Biotec B.V. & Co. KG

17.18. PerkinElmer, Inc.

17.19. PluriSelect Life Science UG & Co. KG

17.20. Promega Corporation

17.21. QIAGEN N.V.

17.22. Stemcell Technologies Inc.

17.23. Takara Bio Inc.

17.24. Terumo BCT, Inc.

17.25. Thermo Fisher Scientific Inc.

18. Key Experts

List of Figures [23]

List of Tables [349]

For more information about this report visit https://www.researchandmarkets.com/r/6hbl6c

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.